Skip to main content
OpenTrials

Clinical trial condition

Digestive System Diseases

Explore clinical trials studying Digestive System Diseases. Study availability and eligibility vary by location and protocol.

31,800 public trials 5,675 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Diseases trial results

Recruiting

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

NCT06582017

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +54 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer Los Angeles, California, United States
  • Cedars-Sanai Medical Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport, California, United States
View Trial Details
Recruiting

Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus

NCT07096193

Conditions
Chronic Disease, Chronic Hepatitis Delta, Digestive System Diseases, +12 more
Locations
  • Investigative Site Anaheim, California, United States
  • University of Louisville, Clinical Trials Unit Louisville, Kentucky, United States
  • University of Maryland, Institute of Human Virology, Clinical Research Unit Baltimore, Maryland, United States
  • The New York-Presbyterian Hospital New York, United States
View all 28 locations
View Trial Details
Recruiting

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

NCT07186842

Conditions
Adnexal Diseases, Advanced Solid Cancers, Bile Duct Diseases, +29 more
Locations
  • SCRI at HCA Health One Denver, Colorado, United States
  • Florida Cancer Specialists Orlando, Florida, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Monash Health Clayton, Australia
View all 17 locations
View Trial Details
Recruiting

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

NCT07227168

Conditions
Cervical Cancer, Colonic Diseases, Colorectal Cancer, +34 more
Locations
  • SCRI Denver Denver, Colorado, United States
  • SCRI FCS Sarasota Sarasota, Florida, United States
  • Mass General Cancer Center Boston, Massachusetts, United States
  • NEXT Austin Austin, Texas, United States
View Trial Details
Recruiting

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

NCT06233461

Conditions
Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
Locations
  • United Medical Doctors Murrieta, California, United States
  • UCI Health Orange, California, United States
  • West Central Gastroenterology, LLP, d/b/a/ Gastro Florida Clearwater, Florida, United States
  • Auzmer Research Lakeland, Florida, United States
View all 190 locations
View Trial Details
Recruiting

Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal Carcinoma

NCT06979869

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +7 more
Locations
  • Gansu Wuwei Cancer Hospital Wuwei, Gansu, China
  • Cancer Hospital Affiliated to Shantou University Medical College Shantou, Guangdong, China
  • Zhaoqing Gaoyao District People's Hospital Zhaoqing, Guangdong, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
View Trial Details
Recruiting

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

NCT07544589

Conditions
Adenocarcinoma Of Esophagus, Adenoviridae Infections, Colonic Diseases, +17 more
Locations
  • City of Hope Duarte, California, United States
  • University of Cincinnati Cancer Center Cincinnati, Ohio, United States
  • Tennessee Oncology Nashville, Tennessee, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
View Trial Details
Recruiting

Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

NCT06698458

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Goodyear, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • Cedars-Sinai Los Angeles, California, United States
View all 15 locations
View Trial Details
Recruiting

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

NCT07409272

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • Mercy Cancer Center Fort Smith, Arkansas, United States
  • Crosson Cancer Institute at Providence St. Jude Medical Center in Fullerton Fullerton, California, United States
  • Cedars-Sinai - Cedars-Sinai Medical Center Los Angeles, California, United States
View all 62 locations
View Trial Details

Related conditions